| Progress, opportunity, and perspective on exosome isolation-efforts for efficient exosome-based theranostics D Yang, W Zhang, H Zhang, F Zhang, L Chen, L Ma, LM Larcher, S Chen, ... Theranostics 10 (8), 3684, 2020 | 778 | 2020 |
| Three decades of nucleic acid aptamer technologies: Lessons learned, progress and opportunities on aptamer development T Wang, C Chen, LM Larcher, RA Barrero, RN Veedu Biotechnology advances 37 (1), 28-50, 2019 | 465 | 2019 |
| Systematic screening of commonly used commercial transfection reagents towards efficient transfection of single-stranded oligonucleotides T Wang, LM Larcher, L Ma, RN Veedu Molecules 23 (10), 2564, 2018 | 231 | 2018 |
| Health-related quality of life and associated factors in patients with myocardial infarction after returning to work: a cross-sectional study R Du, P Wang, L Ma, LM Larcher, T Wang, C Chen Health and quality of life outcomes 18 (1), 1-10, 2020 | 46 | 2020 |
| Therapeutically significant microRNAs in primary and metastatic brain malignancies AA Balachandran, LM Larcher, S Chen, RN Veedu Cancers 12 (9), 2534, 2020 | 37 | 2020 |
| Adverse reactions of targeted therapy in cancer patients: a retrospective study of hospital medical data in China R Du, X Wang, L Ma, LM Larcher, H Tang, H Zhou, C Chen, T Wang BMC cancer 21, 1-13, 2021 | 30 | 2021 |
| Progress, opportunity, and perspective on exosome isolation-efforts for efficient exosome-based theranostics. Theranostics. 2020; 10 (8): 3684–707 D Yang, W Zhang, H Zhang, F Zhang, L Chen, L Ma, LM Larcher, S Chen, ... Epub 2020/03/25. eng, 0 | 26 | |
| DNAzymes: Expanding the Potential of Nucleic Acid Therapeutics LM Larcher, IL Pitout, NP Keegan, RN Veedu, S Fletcher nucleic acid therapeutics 33 (3), 178-192, 2023 | 18 | 2023 |
| Development of novel antimiRzymes for targeted inhibition of miR-21 expression in solid cancer cells LM Larcher, T Wang, RN Veedu Molecules 24 (13), 2489, 2019 | 17 | 2019 |
| Single stranded fully modified-phosphorothioate oligonucleotides can induce structured nuclear inclusions, alter nuclear protein localization and disturb the transcriptome in vitro LL Flynn, R Li, IL Pitout, MT Aung-Htut, LM Larcher, JAL Cooper, KL Greer, ... Frontiers in Genetics 13, 791416, 2022 | 12 | 2022 |
| The health-related quality of life of lung cancer patients with EGFR-TKI-related skin adverse drug reactions and its relationship with coping style and self-management R Du, X Wang, H Zhou, L Ma, LM Larcher, C Chen, T Wang Supportive Care in Cancer 30 (12), 9889-9899, 2022 | 5 | 2022 |
| Derivation of two induced pluripotent stem cell lines from a healthy control subject D Zhang, D Huang, LM Larcher, K Zaw, SC Chen, L Jennings, TM Lamey, ... Stem Cell Research, 103621, 2024 | | 2024 |
| Analysis of Influence Factors of Quality of Life of Lung Cancer Patients with Skin Adverse Drug Reactions Under Targeted Therapy R Du, X Wang, H Zhou, L Ma, LM Larcher, C Chen, T Wang | | 2022 |
| Development of novel oligonucleotide therapeutic molecules targeting microRNAs for tackling brain cancers LM Larcher Murdoch University, 2018 | | 2018 |
